It has garnered significant attention in the neuroscience community
Health Canada has already received at least nine applications from five companies to sell semaglutide duplicates
When melanocytes are hyperactivated by specific triggers UV radiation, post-inflammatory signals from acne or injury, hormonal changes (especially estrogen and progesterone in melasma), or genetic predisposition they produce excess melanin that accumulates in patches, creating dark spots, uneven tone and visible discolouration
Lower cost options without testing documentation may contain impurities, incorrect concentrations, or even entirely different compounds
Weve grouped them into separate drug lists to help make them easier to find
Approval Timeline and Gray-Market Dangers If Phase 3 trials succeed, realistic estimates place a potential FDA submission in the 20262027 range